Navigation Links
TodayMD Renews Race Sponsorship With Alegra Motorsports For A Third Year
Date:1/13/2009

at the most prestigious endurance sports car race in North America, the Rolex 24 at Daytona International Speedway in Daytona Beach, Fla. on Jan. 24-25.

Alegra Motorsports won this event's GT class in 2007. This year it is fielding a Riley BMW Daytona Prototype, No. 22.

At the Rolex 24 the car will be driven by team owner Carlos de Quesada of Coral Gables, Fla.; Scotland's Ryan Dalziel of Orlando, Fla.; Chapman Ducote of Miami Beach, Fla.; Jean-Francois Dumoulin of Trois-Rivieres, Quebec; and the Czech Republic's Tomas Enge of Monte Carlo. It will be driven by Dalziel, de Quesada and Ducote for the subsequent shorter events in the 12-race season. TodayMD will utilize its sponsorship to reach race fans both on and off the track through a variety of racing related promotions. TodayMD, is an innovator in online marketing technology and services for medical and dental practices, as well as other health related organizations, and also has a strategic relationship with Google.

TodayMD is an authorized reseller of Google AdWords. AdWords is an online advertising program designed to help businesses of all sizes use the Web to find new customers by delivering relevant ads when users search for specific products and services. Expanding their search engine marketing (SEM) program to incorporate the Google AdWords offering enables TodayMD to deliver strong search engine marketing strategies to their medical and dental clients while maximizing their marketing dollars. In addition to this service, TodayMD also offers a complete suite of internet marketing solutions including web site development, and search engine optimization, just to name a few.

Created in 1996, Alegra Motorsports has become a name synonymous with sportscar racing. It is comprised of those dedicated to racing and its sole purpose is the participation in sportscar events in the United States and Internationally. We have participated in many sportscar events ranging from auto
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. TodayMD Becomes a Google AdWords Authorized Reseller
2. Wacoal Renews Successful Support the Girls Program
3. Coalition America Renews Relationship with Musketeer to Offer Streamlined Claims Repricing and Adjudication Solution for Benefit Administrators
4. NIH/NCI renews and extends nationwide license for Genomatix software and databases
5. Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
6. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
7. Acclamation Systems, Inc. Renews Partnership with Coalition America to Offer Streamlined Repricing and Adjudication Solution
8. FDA Renews Warnings on Pain-Relief Patch
9. Heart Association Renews Call for CPR Training
10. ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology
11. FDA Renews its Contract with Beaumont Technology Usability Center for Leadership of Patient Safety Project
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
TodayMD Renews Race Sponsorship With Alegra Motorsports For A Third Year
TodayMD Renews Race Sponsorship With Alegra Motorsports For A Third Year
(Date:12/15/2009)... to announce the release of a new report titled, “Incontinence ... for clinical devices used to treat and manage urinary incontinence. ... ... 15, 2009 -- Marketstrat is pleased to announce the release ... The report specifically addresses world markets for clinical devices used ...
(Date:12/15/2009)... study in the Dec. 15 issue of the ... overweight or obese increases the risk for developing obstructive ... children. , Results indicate that the risk ... and older increased 3.5 fold with each standard-deviation increase ... of OSA did not significantly increase with increasing BMI ...
(Date:12/15/2009)... 2009 UT Southwestern Medical Center researchers have ... the unique observable characteristics seen in patients with ... findings, reported online and in the December issue ... Metabolism, suggest that patients with atypical progeroid ... those diagnosed with two similar but more well-defined ...
(Date:12/14/2009)... Dec. 15 In today,s academic medical ... than ever. Now the University HealthSystem Consortium (UHC) ... Value Analysis: Achieving Cost Efficiencies in Health Care, ... complex environments. These new materials, developed with the ... provide a practical guide to planning, implementing, and ...
(Date:12/14/2009)... and NaturalFill™ revolutionary new liposuction and fat transfer treatments can ... all in one minimally invasive treatment. , ... ... AQUALIPO™ and NaturalFill™ can remove excess fat from the abdomen ... people slim down, reduce facial wrinkling and enhance lips all ...
Breaking Medicine News(10 mins):Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 3Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3
... Researchers at the Saint Louis University Institute for Molecular Virology ... cells with HIV virus. ,This discovery will open new doors ... the world. ,It is said that the HIV ... ,One is the Reverse Transcriptase. Secondly it is the Integrase ...
... City Department of Health and Mental Hygiene (DOHMH) has banned ... containing "dangerous levels" of lead and mercury. // , ... Nutrition Board of the Institute of Medicine of the National ... 2 ppm (parts per million) of lead and no more ...
... have successfully operated on 15-month-old twins Mohamed and Souleymane, who ... the first operation of its kind in France. // ... in the steps of similar operations in Britain, South Africa ... division of the La Timone hospital said that at the ...
... by Dr Michael Fenech studied the damage of excess alcohol on ... excess intake of // alcoholic beverages resulted in increased risk of ... the study, six men aged 21-26 stuck to a diet low ... of either complete red wine, red wine with the alcohol removed ...
... genetic link has been discovered by the University of ... this study have been published by the Journal of ... that obese people are prone to develop asthma. The ... between the two conditions. ,The researchers ...
... Vietnamese patients who were infected with the H5N1 bird flu ... Roche drug, Tamiflu. The virus appears to have developed a ... among medical circles. The virus was seen to mutate in ... 274Y resistant strains were seen in both cases. ...
Other Medicine News:Health News:NY Health Dept Bans 3 Ayurveda Drugs 2
(Date:12/15/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that an overall survival benefit would ... surveyed European oncologists in their decision to prescribe ... treatment of breast cancer. ,, The new Special ... European Trends in Targeted Therapies in Breast Cancer: ...
(Date:12/15/2009)... -- OBP Medical Inc. declares victory in the ... in hospitals. ,, Doctors at Newton-Wellesley Hospital in ... OBP Medical,s Under Johnnies(TM) on patients, comfort and ... survey is comparing patients, perception of comfort, privacy ... Under Johnnies(TM) against the traditional hospital gown and ...
(Date:12/14/2009)... -- Embarrassing and sometimes uncomfortable colonoscopies may soon be ... taking note of a new screening test that is ... Knoxville-based company, EDP Biotech Corporation (EDP) is ... medical device doctors can use to screen for colon ... consider that 30% of colon cancer deaths are avoidable ...
Breaking Medicine Technology:For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 2For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 3Under Johnnies(TM) Proven To Increase Patient Satisfaction by OBP Medical Inc. 2EDP Biotech Takes Next Step in the Development of ColoMarker 2EDP Biotech Takes Next Step in the Development of ColoMarker 3New Scientific Worldview Biocentrism Featured in The Huffington Post 231 Weblog in the World 13031 1New Scientific Worldview Biocentrism Featured in The Huffington Post 231 Weblog in the World 13031 2Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages 51721 1Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages 51721 2MedicAlert Foundation and Autism Society Launch New Program to Safeguard Individuals and Families Living With Autism 51717 1MedicAlert Foundation and Autism Society Launch New Program to Safeguard Individuals and Families Living With Autism 51717 2MedicAlert Foundation and Autism Society Launch New Program to Safeguard Individuals and Families Living With Autism 51717 3
... CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 17, 2007 -,AVEO Pharmaceuticals, ... and development of novel, targeted cancer medicines,today ... novel,next generation oral tyrosine kinase inhibitor of ... lung cancer tumor,models. The results from the ...
... Tumor Blood Vessel,Density and Serum PSA Levels ... TUSTIN, Calif., April 17, 2007,/PRNewswire-FirstCall/ -- Peregrine ... developing targeted,monoclonal antibodies for the treatment of ... announced that preclinical data,presented at the Centennial ...
Other Medicine Technology:AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral,Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and,Drug-Resistant Lung Cancer 2AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral,Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and,Drug-Resistant Lung Cancer 3AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral,Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and,Drug-Resistant Lung Cancer 4Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 2Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 3Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 4Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 5
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: